Pain
Commentary
‘Green Whistle’ Provides Pain Relief -- But Not in the US
Methoxyflurane (Penthrox) relieves pain as well as standard care but has been banned in the United States by the FDA.
Latest News
The DEA Plans to Reschedule Marijuana: What Happens Next?
Following 2023 FDA information that legitimized marijuana as a medical treatment, DEA moves to lower its scheduling.
Latest News
More Cases of Acute Diverticulitis Treated Outside Hospital
Current guidelines recommend against prescribing antibiotics or probiotics for most cases because evidence suggests that diverticulitis is...
Latest News
Three Conditions for Which Cannabis Appears to Help
Neuropathic pain, chemotherapy-induced nausea or vomiting, and spasticity in people with multiple sclerosis, may be helped by cannabis.
Conference Coverage
Semaglutide Trial for Knee Osteoarthritis Shows Improvements in Pain, Physical Function
Results of the STEP 9 study in people with knee osteoarthritis and obesity show that semaglutide not only induced significant weight loss but also...
Conference Coverage
Tension, Other Headache Types Robustly Linked to Attempted, Completed Suicide
The results underscore the need for psychiatric evaluations in patients with a headache disorder.
From the Journals
Chronic Pain Linked to Accelerated Brain Aging
The acceleration in brain aging was largely driven by the hippocampus and predicted memory decline and incident dementia during follow-up.
Latest News
Researchers Seek to Block Use of FDA-Approved OUD-Risk Test
Physicians move to stop genetic test aimed at identifying those at risk for opioid addiction.
From the Journals
Virtual Reality Brings Relief to Hospitalized Patients With Cancer
Patients were randomized to receive either 10 minutes of immersive VR distraction therapy or 10 minutes of two-dimensional guided imagery...
Feature
Should Opioids Be Used for Chronic Cancer Pain?
Prescribing strategies are partly driven by peer pressure, new research suggests.
Latest News
Erenumab Linked to Better Migraine Prevention
In patients with resistant episodic migraine, erenumab prevented migraines better than nonspecific oral migraine preventive medications.